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         (Figurel-1) Activation mechanism of C-1027 chromophore
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(Figurel-3) ID plots of the imino preton spectral region of
d(TIG2C3C4A5T6C7)/d(G8A9TleGllG12C13A14) - Chr complex
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(Figurel-4) ID 'H NMR spectra for the free CI027-Chr (upper), the Chr-
d(GIT2A3T4A5C6)2 complex (middle), and the free DNA hexamer (Iower). The
























(Figllrel-5) ID 'H NMR spectra for the free CI027-Chr (upper), the Chr-
d(TIG2C3C4A5T6C7)/d(G8A9TIOGIIG12C13A14) complex (middle), and the
free DNA heptamer (lower). The lines show chemical shift perturbations of the
aromatic protons of the Chr and the DNA oligomer.
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(Figurel-6) H2'/H2" to aromatic H61H8 part of the NOESY spectrum of
the Chr-d(TIG2C3C4A5T6G7)ld(G8A9TIOGIIG12C13A14) complex (upper)
and free DNA oligomer aower).The arrow lines trace the sequential
connectivities from H6/H8 protons to interresidue HZ'/H2".The boxed bases
point to the absence of interresidue NOEs.






















(Figurel-7) Chemical shift changes of d(TIG2C3C4A5T6C7) (upper)




























(Figurel-8) Chemical shift changes of CI027-Chr upsn
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(Figurel-lO) Intermolecular NOEs between DNA and C.1027~Chr
Amlnosugar
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(Figure2-4) Comparison of sequence-specificity in DNA cleav-
ages by holo C-1027 and C-1027 chromephore alon" Lanes 4
and 5 represent holo C-1027- and C-1027 chromophore-induced
DNA cleavages, respectively. Lanes 1 - 3 show intact DNA, C +
T, and G + A of the Maxam-Gilbert sequencing reactions,
respectively.
(Table2-1) inactivation of Holo C-1027 and Its Chromophore Alone"
lnouhaton nme
   (min}form j
        Arnount of DNA (%)
Chromophore


























































"After the respeetive incubation time, the DNA cleavage activity
of the samples was investigated at 37 OC and pH 7.5 for 1O min.








(Figure2-5) Effect of preincubation on DNA cleaving activity ef holQ C-1027 (lanes 1-7) or C-
1027 chromophore (lanes 8-14). Holo C-1027 and C-1027 chromophore were preincilbated at
37 cx)C for 10 min (3, 10), 30 min (4, 11), 60 min (5, 12), 120 min (6, 13), and 180 min (7, 14).
Then, each sample was incubated with supercoiled pBR 322 DNA at 37 cx)C for 10 min. Lanes 2
and 9 show DNA cleaving activities at 37 oeC for 10 min of holo C-1027 and C-1027 chro-
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Emission wavelength (nm)
550  O246E loCencentretlon ot C-1027 apeproteln (pM}
   (Figure2-6) E£fect of C-1027 apopretein on C-I027 chremophore fiuorescence, (A) Changes in fiue-
rescence emission spectra of C-1027 chremephore (10 ISY[) by addition of C-1027 apoprotein. Spectrum 1
shows chromophore alone. The apoprotein was added to the chremophore. solution at G.1 pm (2), O.2 11M
(3), O.3 iAM (4), O.6 ptSd (5), 1.0 pm (6), and 10 lllYE (7). Emission band-pass value was 5 nm. (B) Magnitude
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(Figure2-7) CD spectral ckanges ef C-le27. Lines 1, 2, and 4 shovv the spectra of C-
1027 apoprotein, C-1027 chremophoTe, and hole C-le27, pespectively. Line 3












































































































































































































(Figure3-1) intramolecular ROEs of Cle27-Chr.
       The arrows shows intra-ROEs.
(Table3-Z) Characteristic dihedral angles (deg) of CI027-Chr
        beund to DNA or Ape, and free Chr
ln DNAln Apo Free




(C5}<C4) (C1 3) (C t 4)
























































































































































(Figure C-1) Eight superposed distance-refined solution
structures of DNA-Chr complex.
(Figure C-2) Drawing for binding sites of CI027-Chr with DNA heptamen Side
(left) and front (right) views of the binding interfaces. The strand d(C3C4A5T6)/
d(A9TIOGIIG12) is colored in pink/light blue.
(Figure C-3) NMR model of CI027-Chr - d(GTATAC)2 complex
(Figure C-4) Molecular electrestatic potential of
the binding pocket ofApo, enediyne core, and BO of Chn
(Figure C-5) Whole structure (Ieft) and binding pecket (right) models
of CI027-Apo - Chr complex based on CHARMM calculation.
(Figure C-6) Drawing for binding sites of CI027-Chr with C-1027 Apo. Side (left) and front (right)
views of the binding inter faces. Tyr32-Ser52, Ser74-Thr79,'and Asn92-Alal06 residues composing the




)lution structures of free Chr
, (Figure C-9) Superposition of C-1027 Chr bound to DNA (red) orApo (yellow), and
 free Chr (light blue). The AEB moiety of Chr is superposed upon these three forms.
 A represents stereoview of the whole structures in these three states, and B indicates
        .1 a confermatienal comparison of the MC moieties. Superposed AEB moieties are
 colored green. The viewpoint on the left differs from that on the right in B.
!
(Figure C-7) Drawing for binding sites of CI027-Chr with DNA heptamer (A) and C-1027 Apo
(B). Side (Al and B2) and front (A2 and Bl) views of the binding interfaces. The AEB orientation
of CI027-Chr in Al and A2 is the same as that in Bl and B2, respectively. The strand
d(C3C4A5T6)/d(A9TIOGIIG12) is colored in pink/light blue. Tbrr32-Ser52, Ser74-Thr79, and
Asn92-Alal06 residues composing the pocket ofApo are shown with blue, purple, and pink colors,
respectiyely.
(Figure C-10) Solution structures of CI027-Chr - DNA heptamer complex (left), firee
Chr (center), and CI027-Chr - Apo complex (right). DNA and Apo are represented
with Iight blue in ball-and-stick models. CI027-Chr consists ofAEB (red), MC (green),
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教授）、二木史朗博士（京都大学化学研究所助教授）に深く感謝致します。
貴重な抗生物質C－1027を寛大にご提供下さいました大鵬薬品工業大谷敏夫博士、
C－1027のNMR構造の座標データを親切にもご提供下さいましたサントリー生物有機科
学研究所石黒正路博士に心より感謝致：します。
実験の一部にご協力下さった松本卓甲声：士（第…製薬）、荒木通啓修士、そしてご
指導、ご討議いただいた京都大学化学研究所生体反応設計研究部門nの皆様に深謝い
たします。
最後に、私をこれまであたたかく育んでいただいた父母、祖父母、姉兄、妻にあらた
めて感謝するとともに、時として、主となり、師となり、親となって、私の入生を支
え続けていただいた恩師竹内日遵上人に衷心より感謝申し上げます。
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